Search research articles
Contact Us
Filters
Showing results (471-480 of 480) with videos related to
Page
of 48
Sort By:
You have reached the last page of results.
This site can display upto 480 results.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2008
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
Zachary K Sweeney, Sahaja Acharya, Andrew Briggs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors
Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
Journal of Medicinal Chemistry
|
April 4, 2009
The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine
David B Smith, Genadiy Kalayanov, Christian Sund, et al.
Journal for Immunotherapy of Cancer
|
August 28, 2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, et al.
Life (Basel, Switzerland)
|
March 25, 2022
Biomarkers of Animal Nutrition: From Seasonal to Lifetime Indicators of Environmental Conditions
Rachel A Smiley, Tayler N LaSharr, Heather N Abernathy, et al.
JAMA Oncology
|
June 3, 2019
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study
Thomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 18, 2008
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase
Zachary K Sweeney, James P Dunn, Yu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2021
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Katelyn T Byrne, Courtney B Betts, Rosemarie Mick, et al.
Science Translational Medicine
|
March 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses
Kunle Odunsi, Feng Qian, Amit A Lugade, et al.
Physical Review Letters
|
September 26, 2012
Nanoplasma dynamics of single large xenon clusters irradiated with superintense x-ray pulses from the linac coherent light source free-electron laser
T Gorkhover, M Adolph, D Rupp, et al.
Page
of 48
Search research articles
Search
Showing results (471-480 of 480) with videos related to
Sort By:
Page
of 48
You have reached the last page of results.
This site can display upto 480 results.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2008
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
Zachary K Sweeney, Sahaja Acharya, Andrew Briggs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors
Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
Journal of Medicinal Chemistry
|
April 4, 2009
The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine
David B Smith, Genadiy Kalayanov, Christian Sund, et al.
Journal for Immunotherapy of Cancer
|
August 28, 2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, et al.
Life (Basel, Switzerland)
|
March 25, 2022
Biomarkers of Animal Nutrition: From Seasonal to Lifetime Indicators of Environmental Conditions
Rachel A Smiley, Tayler N LaSharr, Heather N Abernathy, et al.
JAMA Oncology
|
June 3, 2019
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study
Thomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 18, 2008
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase
Zachary K Sweeney, James P Dunn, Yu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2021
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Katelyn T Byrne, Courtney B Betts, Rosemarie Mick, et al.
Science Translational Medicine
|
March 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses
Kunle Odunsi, Feng Qian, Amit A Lugade, et al.
Physical Review Letters
|
September 26, 2012
Nanoplasma dynamics of single large xenon clusters irradiated with superintense x-ray pulses from the linac coherent light source free-electron laser
T Gorkhover, M Adolph, D Rupp, et al.
Page
of 48